A reliable partner in the pharmaceutical market of Russia and the CIS
WIT Pharma supports international and Russian companies across the pharmaceutical market of Russia and the CIS - from market research and health technology assessment to market access and registration under EAEU rules.
Market access Russia & CIS
About us
Expertise proven by time and the market
We help pharmaceutical companies enter the markets of Russia and the CIS, establish themselves and grow - drawing on data, regulatory practice and long-standing industry relationships.
WIT Pharma is a market access partner for pharmaceutical companies in Russia and the CIS - from market research and analysis to access strategy and regulatory support under EAEU rules. Our clients include international corporations, Russian manufacturers and companies from India, China, Turkey and the Middle East.
A particular focus is rare (orphan) diseases and market access strategy in the EAEU. We prepare the analytics and evidence base supporting the review of a product's inclusion in state funding programs (HCN lists, the Krug Dobra foundation), combining our experience in Russia and the CIS with European market-access practice. Thirteen years in the market, projects for dozens of companies and lasting industry relationships.
Compliance
We work to international standards
Transparent procedures and alignment with client requirements are not a formality for us, but a condition for long-term partnership with leading pharmaceutical companies.
- Have passed the due-diligence procedures of international pharmaceutical companies as a service provider
- Operate in accordance with internal standard operating procedures (SOPs) and compliance policies
- Observe anti-corruption requirements, the rules for interaction with healthcare professionals and client data confidentiality
Documents and policies
Ready to sign NDA and DPA. Originals bearing signature and seal are available on request.
Services
Six areas, one outcome - the growth of your business
Market Research & HTA
Quantitative and qualitative analysis of segments, health technology assessment, pharmacoeconomics and real-world data.
Learn moreMarketing Strategy
Market entry strategy for a product and portfolio in Russia and the CIS, lifecycle management, pricing models.
Learn moreMarket Access
Dossiers for the VED list and the 16 High-Cost Nosologies program, cost-effectiveness and budget impact analysis, reimbursement for eligible categories.
Learn moreGR & Regulatory Environment
Monitoring of government initiatives, the national procurement regime, localisation (SPIC, the SSM list).
Learn moreRegistration
Registration of medicines, supplements and medical devices; bringing dossiers into line with EAEU rules.
Learn moreEvent Management
Advisory boards, scientific conferences, regional round tables, engagement with opinion leaders.
Learn moreCases
Market access for international manufacturers
WIT Pharma is a market access agency. We build the access strategy that brings a product into state funding across Russia and the CIS: value substantiation, dossier preparation and materials supporting the review of inclusion in reimbursement lists (VED, high-cost nosologies, regional programs). Below are projects by therapeutic area, anonymized.
30+ products from international manufacturers in market access projects - oncology, rare diseases, cardiometabolic and respiratory medicine.
Bringing targeted and immuno-oncology products into the state funding system (VED, high-cost nosologies).
Market access strategy, substantiation of clinical and economic value, preparation of the dossier and materials supporting the review of inclusion in reimbursement lists.
Access for rare-disease therapies (SMA, coagulation disorders, bone complications) to state funding programs.
Market access support: strategy, target population and budget impact assessment, preparation of the document package for specialized review.
Access for mass-segment therapies (T2DM, heart failure, dyslipidemia, severe asthma, COPD) to reimbursement.
Market access strategy and value substantiation at population level, comparative materials supporting the inclusion decision.
Projects are shown anonymously, in line with our clients' compliance requirements. Details are available on request under NDA.
Team
Leadership
Over 20 years in the pharmaceutical market of Russia and the CIS. Graduate of Sechenov University, the Institute of International Trade and Law and London Business School.
Has held leadership roles in strategy, market access and commercial functions at international and Russian companies. Founder of WIT Pharma. Personally leads market access and GR; assembles a team of senior specialists for each project and owns the outcome for the client.
Network of associate experts
A network of senior associate experts across key disciplines - with experience at international and Russian companies.
Market analytics & research
Quantitative and qualitative market research, competitive analysis and business analytics based on real-world data.
Registration & EAEU
Registration of medicinal products under EAEU rules, bringing dossiers into compliance and managing variations.
Clinical trials
Planning and management of clinical trials and engagement with regulatory authorities.
They trust us
Leading pharmaceutical companies
Our clients include international corporations and Russian manufacturers, from global leaders to local market players.
and other companies of the pharmaceutical market in Russia and the CIS
Testimonials
What clients say
The team has a deep grasp of market access in Russia - CHI and DRG tariffs, pharmacoeconomics. Their analysis passed our internal review and informed our portfolio decisions.
We have worked together for several years. WIT Pharma consistently delivers solid analytics and a level-headed read of the regulatory environment - findings we can rely on for strategic decisions.
A complex market access project delivered professionally and exactly on time: clear communication, well-prepared data, results with no rework needed. Recommended.
Exact references, contacts and project details are provided under NDA on request.
Legislation
Key industry documents
The main regulations governing the circulation of medicines, pricing and public procurement in Russia and the EAEU. Links lead to official sources.
Contacts
Let's discuss your task in the Russian and CIS market
Tell us briefly about the product and the goal - we'll suggest where to start.
Moscow, Presnenskaya Naberezhnaya 12
Federation Tower (Moscow-City), 45th floor, office 82